JOHNSON & JOHNSON

Trading Ideas Johnson & Johnson Bulgaria S.E.

Equities

JNJ

US4781601046

Real-time Estimate Tradegate Other stock markets 15:40:46 20/06/2024 BST			5-day change	1st Jan Change
135.7 ^EUR	-0.43%		-3.13%	-14.26%

03:46pm	J&J: promising results in Crohn's disease	CF
03:38pm	Johnson & Johnson Says Phase 3 Trial of Tremfya to Treat Crohn's Disease Met Co-Primary Endpoints	MT

Trading Ideas

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

JOHNSON & JOHNSON :An end to the technical rebound lies ahead	27/11/19
JOHNSON & JOHNSON :The underlying trend is to the upside	12/06/17
JOHNSON & JOHNSON :Expect the comeback of a strong trend	10/05/17
JOHNSON & JOHNSON :Buying pressure	22/12/16
JOHNSON & JOHNSON :A good level to buy	12/09/16
JOHNSON & JOHNSON :Towards historic highs	26/09/12
JOHNSON & JOHNSON :Beginning of a bearish movement	26/06/12

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

Joseph Wolk, CFO of J&J: End of patent for its flagship drug

January 23, 2024 at 05:30 pm

Secure and Increase the Performance of your Investments with our Team of Experts at your Side

Securing my Investments

fermer